The Absorption Study

Participate in a clinical study of a potential treatment for phenylketonuria (PKU). This is a rare genetic disorder that affects the body’s ability to break down phenylalanine, an amino acid that occurs naturally in many protein-rich foods.

Current treatment options for PKU are a life-long severely restrictive diet and two medicines. One of the medicines does not work for most patients, and the other requires up to 3 injections daily, with an increased risk of anaphylaxis and hypersensitivity. Because of the limited existing treatment options, it is important that new, more efficient treatments are developed.

Call us on 1300 512 434 to discuss your eligibility today!